Primary Mitral Regurgitation Stages A to D

Applies the ACC/AHA chronic PRIMARY mitral regurgitation stages.

Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.

Example

Vena contracta width
0.8 cm
Left ventricular ejection fraction
55 percent
Left ventricular end-systolic dimension
34 mm

Result: stage C2

The tool opens with these values already filled in. Replace them with your own.

What the result means

Stage A
At risk: mild prolapse with normal coaptation, mild leaflet thickening, or previous infective endocarditis, with no more than a trivial jet.
Stage B
Progressive: vena contracta below 0.7 cm, regurgitant volume below 60 mL, fraction below 50 percent, orifice below 0.40 square cm.
Severe
Vena contracta 0.7 cm or more, volume 60 mL or more, fraction 50 percent or more, orifice 0.40 square cm or more.
Stage C1
Asymptomatic severe with a compensated ventricle: ejection fraction ABOVE 60 percent AND end-systolic dimension below 40 mm.
Stage C2
Asymptomatic severe with the ventricle giving way: ejection fraction 60 percent or less, OR end-systolic dimension 40 mm or more.
Stage D
Severe regurgitation with symptoms attributable to it.
60 percent, not 50
The leak unloads the ventricle into a low-pressure atrium, so the measured fraction flatters it. A normal value in severe regurgitation is above 60 percent; 55 percent is dysfunction here.
The dimension alone
An end-systolic dimension of 40 mm or more reaches C2 with a preserved ejection fraction. The ventricle dilating is the earlier signal.
Primary only
These criteria are for a problem of the valve itself. Secondary regurgitation, where the valve is normal and the ventricle or atrium has pulled it open, is staged against its own criteria.

What you enter

  • Vena contracta width
  • Regurgitant volume
  • Regurgitant fraction
  • Effective regurgitant orifice area
  • Left ventricular ejection fraction
  • Left ventricular end-systolic dimension
  • At-risk valve: mild prolapse, leaflet thickening, or previous endocarditis
  • Symptoms attributable to the regurgitation
How this is calculated

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143(5):e72-e227. Read the source ↗

A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.

Browse all tools

Built by Clay Good. Source on GitHub.